https://www.facebook.com/772528345935233/

The Liver Summit

Home
United States
Fort Worth, TX
The Liver Summit

Directions

A multidisciplinary liver education platform by Texas Liver Care. Conferences & educational content. Next Conference: Sept 26, 2026 | DFW

10/07/2026

Some of the best conversations happened between sessions.

New introductions, familiar faces, and ideas exchanged across specialties. Attendees repeatedly highlighted the welcoming atmosphere, approachable faculty, and opportunities for open conversation, exactly what we hoped TLS would create.

Our Sponsor Passport encouraged attendees to explore the exhibits and connect with the teams supporting the day.

The conversations continued into the evening, with live music and a relaxed post-conference reception.

Thank you to everyone who brought such warmth and energy to TLS 2026. These moments capture why meeting in person matters.

10/02/2026

Meet The Liver Summit 2026 Student Scholars!

Our inaugural Student Scholar Program welcomed several local high school students for a day of learning alongside leaders in hepatology and a firsthand introduction to medicine and science.

As AI transforms healthcare, personal mentorship and human connection remain essential to inspiring the next generation of healthcare professionals. That starts with inviting them into the room.

A pleasure to welcome these students, and to see one take the stage to collect a prize!

10/01/2026

A full house in the breakout room for the Madrigal Pharmaceuticals-sponsored Rezdiffra product theater at The Liver Summit (TLS 2026).

Thank you to the Madrigal team for supporting this year’s meeting and to everyone who joined the session.

09/30/2026

Thank you to all our sponsors and supporters for helping bring The Liver Summit (TLS 2026) to life. Your support made it possible to bring together an outstanding faculty and an engaged audience for a memorable day of liver education and connection.

We’re grateful to everyone who backed the vision.

09/30/2026

Last but by no means least at TLS 2026: Dr. Thomas Kerr of UT Southwestern Medical Center closed our program with an update on hepatitis B, including the exciting prospect of a functional cure. He highlighted phase 3 results for investigational bepirovirsen, a glimpse of how treatment could change for some patients living with chronic HBV.

Before his talk, we had the pleasure of recognizing Dr. Kerr’s recent promotion to professor. Making the presentation especially meaningful, the award (from Texas Liver Care) was handed to him by one of his liver transplant recipients.

Congratulations, Dr. Kerr, and thank you for everything you bring to your patients and to hepatology.

Texas Liver Care

09/30/2026

How do we identify risk earlier in cirrhosis, and act before the first decompensation?

At TLS 2026, Dr. Ranjeeta Bahirwani of Baylor Scott & White Health delivered a practical update on the “rule of five,” using liver stiffness and platelet count to risk stratify. In addition to practical insights on preventing decompensation, including early use of carvedilol when clinically significant portal hypertension is identified and the complexities of bleeding and clotting risk in cirrhosis.

A thoughtful talk with a clear goal: keep patients compensated for as long as possible. Thank you, Dr. Bahirwani!

09/30/2026

How can AI make liver care more responsive to patients and more manageable for clinicians?

At TLS 2026, Jeremy Louissaint, MD, of UT Southwestern Medical Center explored practical uses of AI across clinical workflows, patient communication, imaging, and remote monitoring.

He also looked ahead to tools that could help monitor complications of liver disease and support earlier intervention. An excellent discussion of where AI may make a meaningful difference in hepatology.

Thank you, Dr. Louissaint, for bringing this perspective to TLS 2026.

09/30/2026

Dr. Craig Rosenstengle of Baylor Scott & White Health brought a practical update on hepatocellular carcinoma (HCC) and cholangiocarcinoma to TLS 2026.

From the limitations of current HCC surveillance to evolving combination therapies, his talk kept the focus on matching treatment to the patient and stage of disease. He also explored when liver transplantation may be considered for carefully selected patients with small intrahepatic cholangiocarcinoma.

Thank you, Dr. Rosenstengle, for an excellent presentation and for bringing these complex decisions into focus.

Hepatology

09/30/2026

Our closing session at TLS 2026 is underway, expertly moderated by Howard Lee, MD FAST, of Baylor College of Medicine.

Ashwini Mehta DO of Methodist Health System is delivering a practical update on PBC and PSC: how we diagnose PBC, assess risk in PSC, and think about a therapeutic pipeline spanning the gut, immune, biliary, and fibrosis pathways. An excellent look at where care stands and where it may be headed.

09/30/2026

Mazen Noureddin, MD, MHSc, FAASLD of Summit Clinical Research, Houston Methodist brought the room into the conversation at with an incredibly engaging, interactive, case-based presentation on treating MASLD and MetALD.

Through real-world cases, he walked us through fibrosis risk assessment, how to interpret noninvasive tests in context, and the decisions that shape treatment. A practical and memorable way to bring this rapidly evolving field back to the patient in front of us.

Thank you, Dr. Noureddin, for a fantastic presentation!

Hepatology LiverHealth

Address

Fort Worth, TX
76008, 76028, 76036, 76101-76124, 76126-76127, 76130-76137, 76140, 76147-76148,

Website

facebook.com

Alerts

Be the first to know and let us send you an email when The Liver Summit posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.